Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020–2022)

Abstract Background Initial antimicrobial therapy for pneumonia is frequently empirical and resistance to antimicrobial agents represents a great challenge to the treatment of patients hospitalized with pneumonia. We evaluated the frequency and antimicrobial susceptibility of Gram-negative bacteria...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Helio S. Sader, Rodrigo E. Mendes, S. J. Ryan Arends, Timothy B. Doyle, Mariana Castanheira
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2025-01-01
Schriftenreihe:	BMC Pulmonary Medicine
Schlagworte:	Nosocomial pneumonia Enterobacterales CRE Pseudomonas aeruginosa Stenotrophomonas maltophilia Metallo-beta-lactamase
Online-Zugang:	https://doi.org/10.1186/s12890-025-03500-8
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!